Abstract: A first aspect of the present invention is an optical member that blocks straight traveling of light of a second wavelength rather than straight traveling of light of a first wavelength, and is provided with a silicone resin part, and optical material particles dispersed in the silicone resin part, wherein the refractive indexes of the silicone resin part and the optical material particles match at the first wavelength, and do not match at the second wavelength. Consequently, it becomes possible to provide an optical member or the like that selectively transmit a specific wavelength (the first wavelength) by a member different from those of conventional optical elements.

Abstract: The present invention provides a compound capable of being used as an active ingredient of an anti-cancer agent. To provide an anti-cancer agent with few side effects, an object of the present invention is to provide a compound capable of selectively inhibiting the target, i.e., DOCK1, or a salt thereof. The pyridinone compound of the present invention is represented by Formula (1): wherein R1 and R2 are the same or different, and each represents C1-6 alkyl; and R3 is a group represented by, for example, Formula (3) below wherein R5 in the group represented by Formula (3) is hydrogen.

Abstract: A two-dimensional perovskite forming material with an ammonium halide group disposed on its surface can achieve a high carrier mobility. Preferably, the two-dimensional perovskite forming material includes a monolayer that has such an ammonium halide group at a terminal of its molecular structure, and the ammonium halide group in the monolayer is disposed in an ordered fashion on the surface of the material.

Abstract: A medical use honeycomb structure having a plurality of through-holes extending in one direction, wherein an outer peripheral section of the medical use honeycomb structure has a through-hole groove formed by incomplete side walls of the through-hole, and a through-hole inlet adjacent to the through-hole groove.

Abstract: Provided is a composition for a gas seal member that can form a gas seal member for a high-pressure hydrogen device that is capable of sufficiently inhibiting both swelling destruction and blister destruction. The composition for a gas seal member is a composition for a gas seal member used in a high-pressure hydrogen environment and contains an elastomer and fibrous carbon nanostructures. The fibrous carbon nanostructures are contained in a proportion of not less than 1 part by mass and not more than 10 parts by mass per 100 parts by mass of the elastomer. An area fraction S (%) of aggregates of the fibrous carbon nanostructures in a cross-section of the composition for a gas seal member and a volume percentage V (volume %) of the fibrous carbon nanostructures in the composition for a gas seal member satisfy a relationship 0?S/V?2.0.

Abstract: provided is a composition containing electron-donating polymer (D) having a structure represented by the following formula (1), and electron-withdrawing polymer (A) having a structure represented by the following formula (2): wherein definition of the symbols are as described in the DESCRIPTION.

Abstract: Disclosed are an anti-human TIM-3 antibody having high ADCC activity or antibody fragment thereof by screening a monoclonal antibody or antibody fragment thereof which binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure and exhibits ADCC activity; a hybridoma which produces the antibody; a DNA encoding the antibody; a vector comprising the DNA; a transformant which is obtainable by introducing the vector; a method for producing the antibody or the antibody fragment thereof which comprises using the hybridoma or the transformant; and a therapeutic agent and a diagnostic agent comprising the antibody or the antibody fragment thereof as an active ingredient.

Abstract: Provided is a catalyst which comprises a compound represented by formula (1) and which exhibits activity for at least one type of reaction selected from among hydrosilylation reaction or hydrogenation reaction with respect to an aliphatic unsaturated bond and hydrosilane reduction reaction with respect to a carbon-oxygen unsaturated bond or a carbon-nitrogen unsaturated bond. Formula (1): Mn(Lm) {M represents Fe, Co, or Ni having an oxidation number of 0, L represents an isocyanide ligand represented by formula (2), n denotes an integer of 1-8, and m denotes an integer of 2-12. Formula (2): (CN)x—R1 (R1 represents a mono- to trivalent-organic group having 1-30 carbon atoms, optionally being substituted by a halogen atom, and optionally having interposed therein one or more atoms selected from among O, N, S, and Si; and x denotes an integer of 1-3)}.

Abstract: A compound having a structure represented by the following general formula emits delayed fluorescent light, and is useful as a light-emitting material. One or more of R1, R2, R3, R4, and R5 represent a 9-carbazolyl group having a substituent at at least one of 1-position and 8-position, or a 10-phenoxazyl group or 10-phenothiazyl group having a substituent at at least one of 1-position and 9-position. The balance thereof represents a hydrogen atom or a substituent.

Abstract: Provided are a method for diagnosing chronic inflammatory demyelinating polyneuropathy (CIDP), in particular, a diagnostic method for specifically diagnosing a group having a specific pathophysiology among CIDPs, and a kit and a biomarker for use in such a diagnosis. The diagnostic method for diagnosing CIDP of the present invention includes a step of measuring an anti-neurofascin 155 antibody contained in a sample.

Abstract: [Problem] To enable three-dimensional measurement with good precision. [Solution] When three-dimensional measurement is to be performed with good precision using SLAM or the like, images of marks M1, M2, M3, M4 must be captured from various directions by a single-lens camera. In the present invention, directions of imaging by a camera are displayed as sectors C1, C2, C3, C4. For example, it is understood that whereas sectors C1 and C4 have a large central angle and imaging therein is performed from a wide range of directions, sectors C2 and C3 have a small central angle and imaging therein is performed from a narrow range of directions. A photographer seeing such a display can perform additional imaging, and images can therefore be obtained from a wide range of directions, and three-dimensional measurement can be performed with good precision.

Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.

Abstract: A compound represented by formula (I) or formula (1I): in formula (I), R3 represents an electron donating group, R4 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L3 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L4 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L3 and L4 may bond together to form a ring with the carbon atoms to which they are bonded, in formula (II), R5 represents an electron donating group, R6 represents a hydrogen atom, a substituted or unsubstituted aryl group or an electron donating group, L5 represents a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group, L6 represents a single bond, a substituted or unsubstituted heteroarylene group or a substituted or unsubstituted arylene group.

Abstract: A method for producing an organic microdisk structure 40, which is characterized by comprising: a cladding layer formation step 1 wherein a cladding layer 12 is formed by printing a first ink 11 that contains a fluorine-containing hyperbranched polymer on a substrate 10 by an inkjet method; a core layer formation step 2 wherein a core layer 22 is formed by printing a second ink 21 that contains a laser dye and a triazine-based hyperbranched polymer containing no fluorine on the cladding layer 12 by an inkjet method; and an etching step 3 wherein the cladding layer 12 is etched using a solvent 31 that dissolves only the fluorine-containing hyperbranched polymer. Consequently, an unconventional novel method for producing an organic microdisk structure with use of an inkjet method is able to be provided.

Abstract: A mineral processing method capable of efficiently separating a copper mineral from a molybdenum mineral is provided. The mineral processing method includes: a conditioning step of adding sulfite as a surface treatment agent to a mineral slurry containing a copper mineral and a molybdenum mineral; and a flotation step of performing flotation using the mineral slurry after the conditioning step. The hydrophilicity of the copper mineral can be selectively enhanced by sulfite, so as to be able to produce a difference in hydrophilicity between the copper mineral and the molybdenum mineral. Therefore, the molybdenum mineral can be selectively caused to float, and the copper mineral and the molybdenum mineral can be efficiently separated from each other.

Abstract: An anti-inflammatory drug containing a G0/G1 switch 2 (G0S2) inhibitor as an active ingredient is useful as a novel anti-inflammatory drug.

Abstract: An organic electroluminescent device having a donor layer containing a donor compound, a spacer layer containing a spacer compound, and an acceptor layer containing an acceptor compound in that order, wherein the donor compound and the acceptor compound are compounds to form an exciplex to radiate delayed fluorescence, and the excited triplet energy of the spacer compound is higher than the excited triplet energy of the exciplex, can be controlled to have different emission wavelengths not requiring change of the combination of the donor compound and the acceptor compound therein.

Abstract: A laser doping device includes: a solution supply system configured to supply a solution containing dopant to a doping region; a pulse laser system configured to output pulse laser light including a plurality of pulses, the pulse laser light transmitting through the solution; a first control unit configured to control a number of pulses of the pulse laser light for allowing the doping region to be irradiated, and to control a fluence of the pulse laser light in the doping region; and a second control unit configured to control a flow velocity of the solution so as to move bubbles, from the doping region, occurring in the solution every time of irradiation with the pulse.

Abstract: Provided are: a dicyano N-heterocyclic compound represented by formula (I) (in the formula, R3 represents an electron-donating group, and n represents the number of repetitions of the content in brackets and is 0 or 1), the compound having exceptional heat resistance and light emission characteristics; a light-emitting material; and a light-emitting element in which the same is used.

Abstract: Provided is an angle detection device capable of detecting the angle with high sensitivity by a very simple assembly process without requiring complicated processing. The angle detection device is provided with: a rotor (5) which is formed by a disk plate body produced from a magnetic substance having uniaxial magnetic anisotropy, the disk plate body rotating around a center point within the disk plate surface; a stator (3) which is provided to face the plate surface of the disk plate body of the rotor (5), has approximately the same external shape as that of the rotor, and is divided into a plurality of fan-shaped regions, and in which an exciting coil or a detection coil is wound along the outer periphery of each of the divided regions.